Cardinal Health (CAH) EBITDA (2009 - 2026)

Cardinal Health has disclosed EBITDA across 18 years of filings, most recently posting $729.0 million for Q2 2026.

• In Q2 2026, EBITDA rose 70.33% year-over-year to $729.0 million; the TTM figure through Jun 2026 stood at $2.6 billion (up 14.86% YoY), while the FY2026 annual figure was $2.6 billion, up 14.86% from the prior year.
• EBITDA came in at $729.0 million for Q2 2026 at Cardinal Health, up from $509.0 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $730.0 million in Q1 2025 to a low of -$97.0 million in Q1 2022.
• Average EBITDA over 5 years is $379.4 million, with a median of $466.5 million recorded in 2023.
• Year-over-year, EBITDA tumbled 126.02% in 2023 and soared 1875.0% in 2024.
• Over 5 years, EBITDA stood at -$86.0 million in 2022, then surged by 687.21% to $505.0 million in 2023, then rose by 8.71% to $549.0 million in 2024, then grew by 28.78% to $707.0 million in 2025, then increased by 3.11% to $729.0 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $729.0 million in Q2 2026, $509.0 million in Q1 2026, and $707.0 million in Q4 2025.